Target
Illuminate
Cure
Innovative fluorescence imaging against cancer.
SurgiMab is a clinical-stage biotechnology company at the forefront of real-time cancer detection.
Our mission is to improve cancer care through innovative imaging solutions that support earlier detection, better decision making and more effective treatment.
More Precise Surgeries
Surgeons can remove all cancerous tissue while preserving healthy tissue, reducing recurrence risks.
Fewer Complications & Faster Recovery
Less invasive procedures mean reduced side effects, shorter hospital stays, and faster healing.
Better Long-Term Outcomes
Lower chances of cancer recurrence, improved survival rates, and enhanced quality of life.
Earlier and More Accurate Detection
Improved screening leads to earlier diagnosis, increasing treatment success rates.
Pipeline
Tumor targeting fluorescent molecules, engineered to target any solid tumor.
Our values
Innovation
Continuously developing and applying new ideas to drive progress.
Excellence
Committing to the highest standards in everything we do.
Collaboration
Working together across teams and disciplines to achieve common goals.
Patient-centered care
Prioritizing human connection, accessibility, and personalized care.